Bausch Health (BHC)
(Delayed Data from NYSE)
$8.53 USD
+0.17 (2.03%)
Updated Jul 1, 2022 04:00 PM ET
5-Strong Sell of 5 5
A Value C Growth A Momentum A VGM
Company Summary
Based in Laval, Canada, Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of, gastroenterology (GI), and dermatology.
In May 2022, Bausch launched the initial public offering (IPO) for its eye health business, Bausch + Lomb, which subsequently began trading under the ticker "BLCO" on May 6, 2022. Bausch Health will own a 90% majority stake in Bausch + Lomb. However, the IPO for Solta ...
Company Summary
Based in Laval, Canada, Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of, gastroenterology (GI), and dermatology.
In May 2022, Bausch launched the initial public offering (IPO) for its eye health business, Bausch + Lomb, which subsequently began trading under the ticker "BLCO" on May 6, 2022. Bausch Health will own a 90% majority stake in Bausch + Lomb. However, the IPO for Solta Medical has been suspended, due to challenging market conditions and other factors. Solta is Bausch’s medical aesthetics unit with innovative and effective skin rejuvenation and body contouring solutions, including the Thermage RF systems, Fraxel laser, Clear + Brilliant laser and VASER ultrasonic systems. Bausch will revisit alternative paths for Solta in the future.
During the first quarter of 2022, Bausch changed its segment structure in a manner that is consistent with the organizational structure of the two separate entities. The new segment structure resulted in a change to its former Ortho Dermatologics segment, which will now be part of the Diversified Products segment and the Solta business will remain as it is.
Revenues in 2021 came in at $8.4 billion, up 5% from 2020.
General Information
Bausch Health Cos Inc
2150 ST. ELZEAR BLVD. WEST
LAVAL, A8 H7L 4A8
Phone: 514-744-6792
Fax: 514-744-6272
Web: http://www.bauschhealth.com
Email: ir@bauschhealth.com
Industry | Medical - Generic Drugs |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2022 |
Exp Earnings Date | 8/2/2022 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.93 |
Current Year EPS Consensus Estimate | 3.85 |
Estimated Long-Term EPS Growth Rate | 11.30 |
Exp Earnings Date | 8/2/2022 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 8.36 |
52 Week High | 30.30 |
52 Week Low | 6.88 |
Beta | 1.66 |
20 Day Moving Average | 5,811,301.50 |
Target Price Consensus | 28.56 |
4 Week | -6.47 |
12 Week | -63.52 |
YTD | -69.11 |
4 Week | 0.46 |
12 Week | -57.19 |
YTD | -61.51 |
Shares Outstanding (millions) | 360.99 |
Market Capitalization (millions) | 3,079.24 |
Short Ratio | 1.00 |
Last Split Date | 10/16/2000 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 2.22 |
Trailing 12 Months | 2.08 |
PEG Ratio | 0.20 |
vs. Previous Year | -30.77% |
vs. Previous Quarter | -43.31% |
vs. Previous Year | -5.38% |
vs. Previous Quarter | -12.66% |
Price/Book | NA |
Price/Cash Flow | 0.96 |
Price / Sales | 0.37 |
6/30/22 | NA |
3/31/22 | -649.29 |
12/31/21 | -708.85 |
6/30/22 | NA |
3/31/22 | 5.09 |
12/31/21 | 5.40 |
6/30/22 | NA |
3/31/22 | 1.22 |
12/31/21 | 1.08 |
6/30/22 | NA |
3/31/22 | 1.00 |
12/31/21 | 0.89 |
6/30/22 | NA |
3/31/22 | 17.96 |
12/31/21 | 19.00 |
6/30/22 | NA |
3/31/22 | -4.89 |
12/31/21 | -11.24 |
6/30/22 | NA |
3/31/22 | -6.19 |
12/31/21 | -12.14 |
6/30/22 | NA |
3/31/22 | -0.39 |
12/31/21 | -0.09 |
6/30/22 | NA |
3/31/22 | 2.27 |
12/31/21 | 2.27 |
6/30/22 | NA |
3/31/22 | NA |
12/31/21 | NA |
6/30/22 | NA |
3/31/22 | NA |
12/31/21 | NA |